Evicenter
MarkdownMedical informationP&T meetings
Lorundrostat (MLS-101)

Hypertension, in combination with other antihypertensive drugs

Also known as MT-4129
Launch
Not announced
Last updated
198 sources

Product information and disease descriptionProduct descriptionProduct information

Dosage forms and strengths

3 evidence topics · 7 sources

Doses studied in phase 2 and phase 3 trials: 12.5 mg to 100 mg
Commercial strengths and package sizes

No evidence found.